CLASS II ONGOING Drug recall · Reported 17 Jul 2024 · FDA Enforcement Report

Lidocaine HCL Injection, USP 2% 200mg/ (20mg/mL) recalled

Tailstorm Health is recalling Lidocaine HCL Injection, USP 2% 200mg/ (20mg/mL) and Epinephrine HCl 1:200 Dose Vial, distributed nationwide in the US. The recall was initiated on 3 Jul 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number: 2311003, Expiration Date: 11/13/2024
Quantity recalled12,525 10 mL vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0594-2024
FDA event ID
94930
Recalling firm
Tailstorm Health, Chandler, AZ
Classification
Class II
Status
Ongoing
Recall initiated
3 Jul 2024
FDA classified
10 Jul 2024
Reported
17 Jul 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay
Drug class
Pain Medication

Timeline

3 Jul 2024Recall initiated by company
10 Jul 2024Classified by FDA+7 days
17 Jul 2024Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug: reduced efficacy for epinephrine

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Subpotent Drug: reduced efficacy for epinephrine

Which lots are affected?

Lot Number: 2311003, Expiration Date: 11/13/2024

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Tailstorm Health

All 8

Other Lidocaine recalls

All 119